Agilent Technologies, Inc. will pay its quarterly dividend of $0.248 on 7/23/25, Cardinal Health, Inc. will pay its quarterly dividend of $0.5107 on 7/15/25, and Realty Income Corp will pay its ...

In a precedential decision issued on June 11, 2025, the U.S. Court of Appeals for the Federal Circuit (CAFC) affirmed two Patent Trial and Appeal Board (PTAB) inter partes review (IPR) decisions ...

Madison Investments, an investment advisor, released its “Madison Sustainable Equity Strategy” first quarter 2025 investor letter. A copy of the letter can be downloaded here.

Agilent reported Q2 revenue of $1.67 billion and beat EPS estimates. The company raised its 2025 sales forecast and reaffirmed full-year earnings guidance.

Agilent's innovation engine and cost control efforts have been on display through strong growth and margin expansion since spinning out its electronic measurement business Keysight in November 2014.

Agilent Technologies reported a stronger-than-expected second quarter for 2025, with earnings per share (EPS) of $1.31 surpassing analyst forecasts of $1.27. Revenue reached $1.67 billion ...

Agilent Technologies Inc. today announced August Specht, Ph.D., has been named the company’ s Chief Technology Officer. August holds a Bachelor of Science in Chemistry from Queen’ s University ...

Agilent Technologies Inc. (NYSE: A) today announced August Specht, Ph.D., has been named the company’s Chief Technology Officer. Specht, previously vice pres ...

NUGEN® HLD-CD is designed to meet the rigorous demands of healthcare environments. Its broad efficacy spectrum and short contact times make it suitable for all critical areas, including operating ...

Driving Customer-Centric Innovation: Agilent’s Organizational Transformation Agilent realigns its business units to foster deeper collaboration, drive innovation and enhance the value of its solutions ...

The first patient has been dosed in a first-in-human clinical trial evaluating HLD-0915 for metastatic castration-resistant prostate cancer.